PDK4 is decreased in a variety of cancers, such as gastric cancer, prostate cancer, breast cancer, lung cancer and liver cancer, and may be associated with the inhibition of cell proliferation and induction of apoptosis (Liu et al., 2021). This evidence concerns the gene PDK4 and prostate carcinoma.